MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 185 filers reported holding MERIDIAN BIOSCIENCE INC in Q1 2019. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,047,000 | +353.2% | 34,411 | +230.9% | 0.00% | +300.0% |
| Q2 2021 | $231,000 | +102.6% | 10,400 | -23.6% | 0.00% | 0.0% |
| Q1 2020 | $114,000 | -94.0% | 13,621 | -93.0% | 0.00% | -83.3% |
| Q4 2019 | $1,906,000 | +0.6% | 195,063 | -2.3% | 0.01% | -14.3% |
| Q3 2019 | $1,894,000 | -22.5% | 199,615 | -3.0% | 0.01% | -22.2% |
| Q2 2019 | $2,444,000 | -38.6% | 205,736 | -8.9% | 0.01% | -40.0% |
| Q1 2019 | $3,978,000 | +8.5% | 225,902 | +7.0% | 0.02% | -6.2% |
| Q4 2018 | $3,666,000 | -14.1% | 211,138 | -26.3% | 0.02% | 0.0% |
| Q3 2018 | $4,268,000 | -4.8% | 286,471 | +1.6% | 0.02% | -11.1% |
| Q2 2018 | $4,484,000 | +26.3% | 281,955 | +12.7% | 0.02% | +12.5% |
| Q1 2018 | $3,551,000 | – | 250,125 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYQUANT CAPITAL SAS | 134,804 | $4,477 | 11.01% |
| Vazirani Asset Management LLC | 115,774 | $3,845 | 6.51% |
| FIFTH LANE CAPITAL, LP | 185,914 | $6,174,204 | 5.56% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1,939,075 | $64,396,681 | 5.01% |
| Crystalline Management Inc. | 244,453 | $8,118,284 | 4.08% |
| FNY Investment Advisers, LLC | 51,000 | $1,693 | 2.36% |
| HAVENS ADVISORS LLC | 26,800 | $890,028 | 2.26% |
| Euclidean Technologies Management, LLC | 62,995 | $2,092,064 | 1.99% |
| Sand Grove Capital Management LLP | 537,060 | $17,836 | 1.70% |
| Crabel Capital Management, LLC | 120,337 | $3,996 | 1.45% |